Aurora Cannabis Inc. (ACB) Tops Q2 Earnings and Revenue Estimates

Core Viewpoint - Aurora Cannabis Inc. reported quarterly earnings of $0.09 per share, exceeding the Zacks Consensus Estimate of $0.03 per share, and showing a significant increase from $0.04 per share a year ago, representing an earnings surprise of +200.00% [1][2] Financial Performance - The company posted revenues of $65.62 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.88%, and an increase from $59.47 million in the same quarter last year [2] - Over the last four quarters, Aurora Cannabis has exceeded consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Performance and Outlook - Aurora Cannabis shares have increased by approximately 6.8% since the beginning of the year, while the S&P 500 has gained 15.1% [3] - The company's future stock performance will largely depend on management's commentary during the earnings call and the sustainability of the recent earnings numbers [3][4] Earnings Estimates and Revisions - The current consensus EPS estimate for the upcoming quarter is $0.28 on revenues of $69 million, while for the current fiscal year, the estimate is -$0.31 on revenues of $271.75 million [7] - Prior to the earnings release, the trend for estimate revisions was unfavorable, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Medical - Products industry, to which Aurora Cannabis belongs, is currently ranked in the bottom 40% of over 250 Zacks industries, suggesting that the industry outlook may negatively impact stock performance [8]